Cargando…
The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice
Hypercholesterolaemia is a major risk factor for cardiovascular disease and it has been found that some probiotic bacteria possess cholesterol-lowering capabilities. In this study, the ability of the Lab4 probiotic consortium to hydrolyse bile salts, assimilate cholesterol and regulate cholesterol t...
Autores principales: | Michael, D. R., Davies, T. S., Moss, J. W. E., Calvente, D. Lama, Ramji, D. P., Marchesi, J. R., Pechlivanis, A., Plummer, S. F., Hughes, T. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460276/ https://www.ncbi.nlm.nih.gov/pubmed/28588193 http://dx.doi.org/10.1038/s41598-017-02889-5 |
Ejemplares similares
-
Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
por: O’Morain, Victoria L., et al.
Publicado: (2023) -
ANTI-CHOLESTEROLAEMIC ACTIVITY OF A FRACTION OF AZADIRACHTA INDICA LEAF EXTRACT ON RATS
por: Mukherjee, Pulok K., et al.
Publicado: (1995) -
Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
por: Michael, D. R., et al.
Publicado: (2021) -
Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high fat diet
por: Moss, Joe W. E., et al.
Publicado: (2021) -
A Direct Comparison of Metabolic Responses to High-Fat Diet in C57BL/6J and C57BL/6NJ Mice
por: Fisher-Wellman, Kelsey H., et al.
Publicado: (2016)